Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Menarini to co-market Orion's EasyHaler

Executive Summary

Orion Corp. and Menarini Group will co-market the former's budesonide/formoterol Easyhaler combination product for asthma and chronic obstructive pulmonary disease in Germany, Italy, Spain, and Portugal.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Marketing
    • Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register